T1	Pharmacological_substance 738 752	corticosteroid
T2	GGPs 1483 1488	CCL13
T10	Disorder 854 860	asthma
T15	GGPs 1476 1481	CCL17
T16	GGPs 796 801	TGF-β
T18	GGPs 765 774	Periostin
T22	GGPs 1400 1409	periostin
T23	Anatomical_entity 876 885	bronchial
T24	Anatomical_entity 970 976	airway
T25	Anatomical_entity 573 579	sputum
T29	Disorder 1254 1260	asthma
T30	Disorder 102 108	asthma
T32	Pharmacological_substance 1278 1290	Lebrikizumab
T38	Artificial_process 322 329	therapy
T39	Subject 1083 1093	asthmatics
T43	Subject 1445 1453	subgroup
T44	Anatomical_entity 1470 1475	Serum
T45	GGPs 8 17	periostin
T46	Subject 244 252	Patients
T48	Pharmacological_substance 1527 1539	lebrikizumab
T51	GGPs 1009 1028	monoclonal antibody
T53	Artificial_process 1123 1132	treatment
T60	Disorder 513 542	idiopathic pulmonary fibrosis
T61	Disorder 815 837	subepithelial fibrosis
T63	Pharmacological_substance 1044 1056	Lebrikizumab
T72	GGPs 925 934	Periostin
T73	Pharmacological_substance 662 669;683 698	inhaled corticosteroids
T77	GGPs 1435 1444	periostin
T78	Pharmacological_substance 991 1003	Lebrikizumab
T81	Method_cue 584 601	bronchial  biopsy
T82	Disorder 125 131	Asthma
T86	GGPs 914 923	periostin
T87	Disorder 505 511	asthma
T88	Pharmacological_substance 1151 1163	beta agonist
T90	Subject 1410 1418	subgroup
T92	Disorder 547 551	COPD
E4	Artificial_process:T38 Instrument:T20 Theme:T46
E6	Artificial_process:T53 Instrument:T88 Theme:T39
N5	Reference T1 UMLS:C3536709	Corticosteroid [EPC]
N8	Reference T2 UMLS:C0390071	Monocyte Chemoattractant Protein 4
N45	Reference T10 UMLS:C0004096	Asthma
N61	Reference T15 UMLS:C0539535	CCL17 protein, human
N80	Reference T18 UMLS:C0219433	POSTN protein, human
N95	Reference T22 UMLS:C0219433	POSTN protein, human
N98	Reference T23 UMLS:C0205039	Bronchial
N103	Reference T24 UMLS:C0458827	Airway structure
N105	Reference T25 UMLS:C0038056	Sputum
N120	Reference T29 UMLS:C0004096	Asthma
N124	Reference T30 UMLS:C0004096	Asthma
N130	Reference T32 UMLS:C2981360	lebrikizumab
N151	Reference E4 UMLS:C0087111	Therapeutic procedure
N177	Reference T44 UMLS:C0229671	Serum
N183	Reference T45 UMLS:C0219433	POSTN protein, human
N185	Reference T46 UMLS:C0030705	Patients
N194	Reference T48 UMLS:C2981360	lebrikizumab
N214	Reference T51 UMLS:C0003250	Monoclonal Antibodies
N225	Reference E6 UMLS:C0087111	Therapeutic procedure
N259	Reference T60 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N262	Reference T61 UMLS:C3553304	Subepithelial fibrosis
N268	Reference T63 UMLS:C2981360	lebrikizumab
N308	Reference T72 UMLS:C0219433	POSTN protein, human
N339	Reference T77 UMLS:C0219433	POSTN protein, human
N343	Reference T78 UMLS:C2981360	lebrikizumab
N350	Reference T81 UMLS:C0740463	Biopsy of bronchus
N352	Reference T82 UMLS:C2984299	Asthma Pathway
N353	Reference T82 UMLS:C0004096	Asthma
N366	Reference T86 UMLS:C0219433	POSTN protein, human
N370	Reference T87 UMLS:C0004096	Asthma
E10	Correlation:T21 Theme:T45 Theme2:T94 Theme3:T95 Theme4:T54 Theme5:T97 Theme6:T8 Theme7:T98 Theme8:T30
T94	Measurement 19 23	FENO
T95	GGPs 25 30	IL-13
T97	GGPs 51 67	IL-13 antagonist
T98	GGPs 82 98	IL-13 antagonist
T54	Pharmacological_substance 32 43	lebrikzumab
N1	Reference T54 UMLS:C2981360	lebrikizumab
T8	GGPs 77 81;88 98	IL-4 antagonist
T19	Disorder 265 271	asthma
A1	Organism_sbjct T46 Human
A2	Patient_sbjct T46 Patient
R1	Subject_Disorder Arg1:T46 Arg2:T19	
T20	Method_cue 350 374	new treatment approaches
T3	GGPs 376 381	IL-13
T26	Disorder 423 438	allergic asthma
T34	Positive_regulation 411 419	mediator
E7	Positive_regulation:T34 Cause:T3 Theme:T26
A3	Speculated E7
T6	GGPs 456 461	IL-13
E17	Correlation:T89 Theme:T6 Theme2:E46
E18	Correlation:T91 Theme:T6 Theme2:E44
E19	Correlation:T89 Theme:T6 Theme2:E45
T35	GGPs 553 558	IL-13
T52	Gene_expression 559 565	levels
E16	Gene_expression:T52 atLoc:T25 Theme:T35
T56	Disorder 636 642	asthma
T11	Positive_regulation 617 625	elevated
E20	Positive_regulation:T11 Theme:E21 disorder:T56
T14	Anatomical_entity 584 593	bronchial
E21	Gene_expression:T52 atLoc:T14 Theme:T35
T37	Artificial_process 655 658	use
E22	Artificial_process:T37 Instrument:T73 Theme:T93
E23	Positive_regulation:T11 Theme:E16 disorder:T56
T59	GGPs 706 711	IL-13
T64	Positive_regulation 775 783	enhances
T68	Correlation 838 848	associated
E28	Correlation:T68 Theme:T61 Theme2:T10
T70	GGPs 862 867	IL-13
T71	Positive_regulation 868 875	induces
E29	Positive_regulation:T71 Cause:T70 Theme:E30
T74	Localization 906 913	secrete
E30	Localization:T74 Theme:T86 toLoc:T7
T7	Cell 886 902	epithelial cells
N4	Reference T7 UMLS:C0014597	Epithelial Cells
R2	part_of Arg1:T7 Arg2:T23	
T17	Positive_regulation 962 969	induced
E2	Positive_regulation:T17 Theme:E1 Cause:T75
T75	Cell 958 961	Th2
T31	GGPs 1037 1042	IL-13
A7	Organism_sbjct T39 Human
A8	Patient_sbjct T39 Patient
R3	member_of Arg1:T78 Arg2:T51	
T12	Pharmacological_substance 1168 1191	inhaled corticosteroids
N7	Reference T12 UMLS:C4020618	Anti-inflammatories, Inhaled Corticosteroids
E31	Artificial_process:T53 Instrument:T12 Theme:T39
T5	Positive_regulation 1057 1065	improved
E32	Positive_regulation:T5 Theme:E33 Cause:T63
T27	Biological_process 1066 1079	lung function
E33	Biological_process:T27 atLoc:T39
N9	Reference E33 UMLS:C0035245	Respiratory physiology
T28	Negative_regulation 1291 1296	block
T47	GGPs 1297 1302	IL-13
T66	GGPs 1325 1333	IL-13Rα1
T79	GGPs 1334 1349	IL-4Rα receptor
T9	Measurement 1383 1387	FENO
T33	Negative_regulation 1370 1379	reduction
E3	Negative_regulation:T33 Theme:T9 atLoc:T90 Cause:T22
T40	GGPs 1499 1502	IgE
T41	Gene_expression 1503 1509	levels
E5	Gene_expression:T41 Theme:T2 atLoc:T44
E36	Gene_expression:T41 Theme:T15 atLoc:T44
E37	Gene_expression:T41 Theme:T40 atLoc:T44
T50	Negative_regulation 1510 1519	decreased
E38	Negative_regulation:T50 Cause:T48 atLoc:T83 Theme:E36
A9	Organism_sbjct T43 Human
A10	Patient_sbjct T43 Patient
A11	Organism_sbjct T90 Human
A12	Patient_sbjct T90 Patient
T83	Subject 1540 1545	group
A13	Organism_sbjct T83 Human
A14	Patient_sbjct T83 Patient
E9	Negative_regulation:T50 Theme:E37 Cause:T48 atLoc:T83
E39	Negative_regulation:T50 Theme:E5 Cause:T48 atLoc:T83
N20	Reference T95 UMLS:C3658037	interleukin-13, human
N23	Reference T3 UMLS:C3658037	interleukin-13, human
N25	Reference T6 UMLS:C3658037	interleukin-13, human
N26	Reference T35 UMLS:C3658037	interleukin-13, human
N27	Reference T59 UMLS:C3658037	interleukin-13, human
N28	Reference T70 UMLS:C3658037	interleukin-13, human
N29	Reference T31 UMLS:C3658037	interleukin-13, human
N30	Reference T47 UMLS:C3658037	interleukin-13, human
N31	Reference T19 UMLS:C0004096	Asthma
N32	Reference T26 UMLS:C0155877	Allergic asthma
N33	Reference T56 UMLS:C0004096	Asthma
N34	Reference T20 UMLS:C0087111	Therapeutic procedure
N35	Reference T92 UMLS:C0024117	Chronic Obstructive Airway Disease
N36	Reference T14 UMLS:C0205039	Bronchial
N37	Reference E22 UMLS:C0087111	Therapeutic procedure
N38	Reference T73 UMLS:C4020618	Anti-inflammatories, Inhaled Corticosteroids
T55	Pharmacological_substance 674 698	systemic corticosteroids
E40	Artificial_process:T37 Instrument:T55 Theme:T93
N39	Reference E40 UMLS:C0087111	Therapeutic procedure
N3	Reference T16 UMLS:C0040690	Transforming Growth Factor beta
N40	Reference T75 UMLS:C0242633	T-helper cell type 2
N41	Reference T88 UMLS:C0001644	Adrenergic beta-Agonists
N42	Reference E31 UMLS:C0087111	Therapeutic procedure
N16	Reference T79 UMLS:C1620077	IL4R protein, human
N13	Reference T66 UMLS:C1528378	IL13RA1 protein, human
N10	Reference T40 UMLS:C0020846	Immunoglobulin E
N12	Reference E21 UMLS:C0017262	Gene Expression
N17	Reference E16 UMLS:C0017262	Gene Expression
N18	Reference E36 UMLS:C0017262	Gene Expression
N19	Reference E5 UMLS:C0017262	Gene Expression
N21	Reference E37 UMLS:C0017262	Gene Expression
T4	Biological_process 977 989	inflammation
E1	Biological_process:T4 Theme:T24
N22	Reference E1 UMLS:C0021368	Inflammation
T57	Artificial_process 1221 1230	treatment
E41	Artificial_process:T57 Theme:T29
T42	Biological_process 784 795	profibrotic
T69	Positive_regulation 1196 1204	provided
E43	Positive_regulation:T69 Cause:T63 Theme:E41
N43	Reference E43 UMLS:C1879547	Activation
N44	Reference E32 UMLS:C1879547	Activation
T80	Biological_process 489 501	pathogenesis
E44	Biological_process:T80 Theme:T60
E45	Biological_process:T80 Theme:T92
E46	Biological_process:T80 Theme:T87
N46	Reference E46 UMLS:C0699748	Pathogenesis
N47	Reference E45 UMLS:C0699748	Pathogenesis
N48	Reference E44 UMLS:C0699748	Pathogenesis
T84	Binding 1029 1036	against
E47	Binding:T84 Theme:T31 Theme2:T78
T85	Pathway 796 811	TGF-β signaling
E48	Pathway:T85 Participant:T16
N49	Reference E48 UMLS:C1515163	TGF Beta Signaling Pathway BioCarta
E49	Biological_process:T42 Theme:E48 disorder:T61
N50	Reference E49 UMLS:C0596570	fibrogenesis
E50	Positive_regulation:T64 Cause:T18 Theme:E49
N52	Reference E50 UMLS:C1654620	
N53	Reference E28 UMLS:C0332281	Associated with
T65	Pathway 1297 1312	IL-13 signaling
E51	Pathway:T65 Participant:T47 Participant2:T66 Participant3:T79
N54	Reference E51 UMLS:C3158959	interleukin-13-mediated signaling pathway
E52	Negative_regulation:T28 Cause:T32 Theme:E51
N56	Reference E52 UMLS:C3463820	Inhibition
N69	Reference E7 UMLS:C1879547	Activation
N70	Reference E20 UMLS:C1879547	Activation
N71	Reference E23 UMLS:C1879547	Activation
N73	Reference E29 UMLS:C1879547	Activation
N74	Reference E2 UMLS:C1879547	Activation
N75	Reference E3 UMLS:C3463820	Inhibition
N76	Reference E38 UMLS:C3463820	Inhibition
N77	Reference E39 UMLS:C3463820	Inhibition
N78	Reference E9 UMLS:C3463820	Inhibition
T89	Correlation 471 481	implicated
N66	Reference E19 UMLS:C0332281	Associated with
T91	Correlation 471 481	implicated
N67	Reference E18 UMLS:C0332281	Associated with
N68	Reference E17 UMLS:C0332281	Associated with
T36	Correlation 726 734	involved
E53	Correlation:T36 Theme:T59 Theme2:E54
T96	Biological_process 738 763	corticosteroid resistance
E54	Biological_process:T96 
N79	Reference E54 UMLS:C0521859	Drug resistance to corticoids
N72	Reference E53 UMLS:C0332281	Associated with
R4	Disorder_association Arg1:T61 Arg2:T10	
T62	GGPs 944 953	biomarker
N6	Reference T62 UMLS:C0005516	Biological Markers
N82	Reference E41 UMLS:C0087111	Therapeutic procedure
T21	Correlation 0 4	Role
N65	Reference E10 UMLS:C0332281	Associated with
T67	Entity_Property 258 264	severe
T76	Entity_Property 629 635	severe
T93	Subject 636 642	asthma
R5	Subject_Disorder Arg1:T93 Arg2:T56	
R6	part_of Arg1:T25 Arg2:T93	
R7	part_of Arg1:T14 Arg2:T93	
T99	GGPs 717 725	mediator
R8	member_of Arg1:T59 Arg2:T99	
N2	Reference E30 UMLS:C1744691	establishment and maintenance of localization
R9	member_of Arg1:T72 Arg2:T62	
R10	part_of Arg1:T44 Arg2:T83	
T13	Entity_Property 1234 1240	severe
T49	Disorder 1083 1093	asthmatics
R11	Subject_Disorder Arg1:T39 Arg2:T49	
N11	Reference T49 UMLS:C0004096	Asthma
N24	Reference E47 UMLS:C1167622	Binding (Molecular Function)
A4	Organism_sbjct T93 Human
A5	Patient_sbjct T93 Patient
N51	Reference T93 UMLS:C0030705	Patients
N55	Reference T39 UMLS:C0030705	Patients
N57	Reference T90 UMLS:C0030705	Patients
N14	Reference T43 UMLS:C0030705	Patients
N15	Reference T83 UMLS:C0030705	Patients
